Publications of Reinhard Hohlfeld
All genres
Journal Article (119)
2012
Journal Article
287 (25), pp. 20986 - 20995 (2012)
Target specificity of an autoreactive pathogenic human gamma delta-T cell receptor in myositis. The Journal of Biological Chemistry
Journal Article
209 (3), pp. 521 - 535 (2012)
Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration. Journal of Experimental Medicine
Journal Article
22, pp. 607 - 618 (2012)
Prospects of transcript profiling for mRNAs and microRNAs using formalin fixed and paraffin embedded dissected autoptic multiple sclerosis lesions. Brain Pathology
Journal Article
22 (5), pp. 607 - 618 (2012)
Prospects of transcript profiling for mRNAs and microRNAs using formalin-fixed and paraffin-embedded dissected autoptic multiple sclerosis lesions. Brain Pathology
Journal Article
18 (12), pp. 1743 - 1745 (2012)
Ion channels boost axonal injury in multiple sclerosis. Nature Medicine
Journal Article
4 (145), 145fs24 (2012)
β-Amyloid: Enemy or remedy? Science translational medicine: Integrating medicine and science
Journal Article
8 (11), pp. 613 - 623 (2012)
B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nature Reviews Neurology
Journal Article
319 (1-2), pp. 2 - 7 (2012)
Viability of autoantibody-targets: How to tackle pathogenetic heterogeneity as an obstacle for treatment of multiple sclerosis. JOURNAL OF THE NEUROLOGICAL SCIENCES
Journal Article
79 (23), pp. 2241 - 2248 (2012)
Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology
Journal Article
18 (5), pp. 824 - 828 (2012)
Unbiased identification of target antigens of CD8(+) T cells with combinatorial libraries coding for short peptides. Nature Medicine 2011
Journal Article
179 (3), pp. 1347 - 1359 (2011)
Inclusion body myositis laser microdissection reveals differential up-regulation of IFN-gamma signaling cascade in attacked versus nonattacked myofibers. American Journal of Pathology
Journal Article
7 (1), pp. 56 - 59 (2011)
The emerging role of microRNAs in multiple sclerosis. Nature Reviews Neurology
Journal Article
17 (4), pp. 495 - 497 (2011)
Drug-induced Sweet's syndrome after mitoxantrone therapy in a patient with multiple sclerosis. Multiple Sclerosis Journal
Journal Article
306 (1-2), pp. 180 - 182 (2011)
Humoral autoimmunity in multiple sclerosis. Journal of the Neurological Sciences
Journal Article
233 (1-2), pp. 245 - 248 (2011)
Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin. Journal of Neuroimmunology
Journal Article
76 (15), pp. 1310 - 1315 (2011)
Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab. Neurology
Journal Article
77 (6), pp. 580 - 588 (2011)
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 2010
Journal Article
16 (12), pp. 1517 - 1520 (2010)
Concurrent TNFRSF1A R92Q and pyrin E230K mutations in a child with multiple sclerosis. Multiple Sclerosis
Journal Article
88 (8), pp. 753 - 761 (2010)
Axo-glial antigens as targets in multiple sclerosis: Implications for axonal and grey matter injury. Journal of Molecular Medicine
Journal Article
16 (1), pp. 3 - 14 (2010)
'Gimme five': Future challenges in multiple sclerosis. ECTRIMS Lecture 2009. Multiple Sclerosis Journal